RegeneRx Biopharmaceuticals Inc (RGRX):財務・戦略的SWOT分析

◆英語タイトル:RegeneRx Biopharmaceuticals Inc (RGRX) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
◆調査対象地域:United States
◆産業分野:Pharmaceuticals and Healthcare
Site License(同一事業所内共有可)USD600 ⇒換算¥82,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥124,200見積依頼/購入/質問フォーム


RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its business development services include clinical development and commercialization interests in desired pharmaceutical therapeutic fields for suitable infrastructure, expertise and a long-term initiative in disease areas. RegeneRx’s research areas include neurologic and stroke; cytoskeletal research; renal disease, renal organogenesis and fibrosis; dermal scarring, stem cell, cardiovascular reperfusion injury, ophthalmic mechanisms of repair, cosmeceuticals, burns and pulmonary arterial hypertension. The company conducts research and development on novel pharmaceuticals, which protect and repair tissue and organ damage. It collaborates with universities, hospitals, and medical research institutions worldwide. RegeneRx is headquartered in Rockville, Maryland, the US.

RegeneRx Biopharmaceuticals Inc Key Recent Developments

Mar 18,2021: RegeneRx Reports Topline Results of ARISE-3 Dry Eye Trial
Feb 24,2021: RegeneRx JV Locks Clinical Trial Database for Phase 3 Dry Eye Trial
Sep 08,2020: New research paper suggests RegeneRx’s thymosin beta 4 may be useful in treating COVID-19

This comprehensive SWOT profile of RegeneRx Biopharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of RegeneRx Biopharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

RegeneRx Biopharmaceuticals Inc – Key Information
RegeneRx Biopharmaceuticals Inc – Overview
RegeneRx Biopharmaceuticals Inc – Key Employees
RegeneRx Biopharmaceuticals Inc – Key Employee Biographies
RegeneRx Biopharmaceuticals Inc – Key Operational Heads
RegeneRx Biopharmaceuticals Inc – Major Products and Services
RegeneRx Biopharmaceuticals Inc – History
RegeneRx Biopharmaceuticals Inc – Company Statement
RegeneRx Biopharmaceuticals Inc – Locations And Subsidiaries
RegeneRx Biopharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

RegeneRx Biopharmaceuticals Inc – Business Description
RegeneRx Biopharmaceuticals Inc – Corporate Strategy
RegeneRx Biopharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
RegeneRx Biopharmaceuticals Inc – Strengths
RegeneRx Biopharmaceuticals Inc – Weaknesses
RegeneRx Biopharmaceuticals Inc – Opportunities
RegeneRx Biopharmaceuticals Inc – Threats
RegeneRx Biopharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

RegeneRx Biopharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

RegeneRx Biopharmaceuticals Inc, Key Information
RegeneRx Biopharmaceuticals Inc, Key Ratios
RegeneRx Biopharmaceuticals Inc, Share Data
RegeneRx Biopharmaceuticals Inc, Major Products and Services
RegeneRx Biopharmaceuticals Inc, History
RegeneRx Biopharmaceuticals Inc, Key Employees
RegeneRx Biopharmaceuticals Inc, Key Employee Biographies
RegeneRx Biopharmaceuticals Inc, Key Operational Heads
RegeneRx Biopharmaceuticals Inc, Other Locations
RegeneRx Biopharmaceuticals Inc, Subsidiaries
RegeneRx Biopharmaceuticals Inc, Key Competitors
RegeneRx Biopharmaceuticals Inc, SWOT Analysis
RegeneRx Biopharmaceuticals Inc, Ratios based on current share price
RegeneRx Biopharmaceuticals Inc, Annual Ratios
RegeneRx Biopharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios


★リサーチレポート[ RegeneRx Biopharmaceuticals Inc (RGRX):財務・戦略的SWOT分析(RegeneRx Biopharmaceuticals Inc (RGRX) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。